Accessibility Links

Medical Affairs

Designing and implementing critical strategies, managing complex, multi-country projects

  Help commercialize products, optimise performance, provide value input and expertise


We have fantastic UK and Global opportunities in our Medical Affairs Department, as Managers, Directors and Associate Directors.

Responsibilities as an Associate Director or Manager include creating and developing Medical Affairs teams, including Medical Science Liaison Managers and Clinical Trial Educators. Using your expertise, you’ll ensure that the delivery of information is compliant with regulations governing scientific communications. You’ll be responsible for helping to create and execute medical and scientific strategies for brands, providing high-quality medical input to marketing and operational plans for promoted products, working with IQVIA Commercial and Market Access.

Work in a dynamic, matrixed environment at IQVIA.

Let’s move healthcare forward. Together.

Set up a job alert

Our jobs

Medical Director, Medical and Patient Communications
  • City / Town Reading
  • Medical Communications Writing DirectorLocation: ReadingIQVIA are looking for a Medical Director to join our Medical and Patient Communications team. In this key role, you will
Medical Science Liaison - Biosimilars and Oncology - Germany
  • City / Town Mannheim
  • New Team BuildOur client, is a global biopharmaceutical company dedicated to bringing biosimilar medicines to market and transforming the way biologic therapies are brought to
Medical Science Liaison – Hematology-Oncology - Southern Europe
  • City / Town Milan
  • Our client, is an US Biopharmaceutical company with a focus on developing and bringing to market novel targeted therapies covering a range of blood related cancers.The medical
Medical Science Liaison - Oncology - Italy
  • City / Town Milano
  • IQVIA™ is the leading human data science company focused on helping healthcare clients find unparalleled insights and better solutions for patients. Formed through the merger of